​
Login / Signup
Zixing Wang
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Combination Therapy
Low Grade
Ankylosing Spondylitis
Free Survival
Top Venues
Pharmaceutical statistics
Blood cancer discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Simone Filosto
,
Saran Vardhanabhuti
,
Miguel A Canales
,
Xavier Poire
,
Lazaros J Lekakis
,
Sven de Vos
,
Craig A Portell
,
Zixing Wang
,
Christina To
,
Marco Schupp
,
Soumya Poddar
,
Tan Trinh
,
Carmen M Warren
,
Ethan G Aguilar
,
Justin Budka
,
Paul Cheng
,
Justin Chou
,
Adrian Bot
,
Rhine R Shen
,
Jason R Westin
Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7).
Blood cancer discovery
(2023)
Zixing Wang
,
Qingyang Zhang
,
Allen Xue
,
James Whitmore
Sample size calculation for mixture model based on geometric average hazard ratio and its applications to nonproportional hazard.
Pharmaceutical statistics
23 (3) (2023)
Zixing Wang
,
Qingyang Zhang
,
Allen Xue
,
James Whitmore
Sample size calculation for mixture model based on geometric average hazard ratio and its applications to nonproportional hazard.
Pharmaceutical statistics
(2023)